AMY CORREOSO: Open Payments
NPI 1003205063 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,152 in 48 payments from 14 companies in 2025. Trend: 2023 $2,491 · 2024 $3,298 · 2025 $1,152
Food & beverage: $1,152
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $220 |
| UCB, Inc. | 7 | $197 |
| Novartis Pharmaceuticals Corporation | 5 | $139 |
| GENZYME CORPORATION | 4 | $118 |
| PFIZER INC. | 4 | $89 |
| ABBVIE INC. | 3 | $70 |
| Incyte Corporation | 3 | $68 |
| Almirall LLC | 3 | $57 |
| Lilly USA, LLC | 2 | $49 |
| LEO Pharma Inc. | 2 | $48 |
Products named: TREMFYA, Bimzelx, DUPIXENT, COSENTYX, SKYRIZI, OPZELURA, CIBINQO, EBGLYSS.
Industry payments across FL — which companies pay providers there.
